Advances in PrEP What Has Been Achieved Which Challenges Remain_Anca Streinu-Cercel

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

19th INTEREST 2025

First Speaker Against the Proposition - Everline Ashiono, MMed, MBChB

INTEREST 2024

First Speaker Against the Proposition - Everline Ashiono, MMed, MBChB

INTEREST 2024

Eliminating HIV in Children - Why is Africa Behind? - Ivy Kasirye, MBChB, MMed, MSc

INTEREST 2024

Eliminating HIV in Children - Why is Africa Behind? - Ivy Kasirye, MBChB, MMed, MSc

INTEREST 2024

HPV and HIV Elimination of a double burden_Sabrina Kitaka_INTEREST_2024.pdf

INTEREST 2024

Differentiated HIV Care for Adolescents living with HIV_INTEREST 2024_Sabrina Kitaka_FINAL FINAL.pdf

INTEREST 2024

Update on Long Acting ART for PrEP and Treatment - François Venter, MD, FCP, PhD

INTEREST 2024

Kidney Impairment in HIV: An Insight Into the Burden and Associated Factors Among Adults on Antiretroviral Therapy (ART) in Zambia - Matenge Mutalange, Zambia

INTEREST 2024

Prevalence and Associated Factors of Chronic Kidney Disease in Young People Living With HIV in Uganda - Esther Nasuuna, Uganda

INTEREST 2024

C-Reactive Protein (CRP) and HIV Are Independent Predictors of Cognitive Performance Among Children and Adults From Kampala, Uganda - Lois Bayigga, Uganda

INTEREST 2024

Silent Struggles Unveiled: High Prevalence of Depression, Suicidal Behavior, and Substance Abuse Among Adolescents and Young Adults Living With HIV Select Facilities in Malawi - Louiser Upile Kalitera, Malawi

INTEREST 2024

Distribution et Determinants du Risque D’Evenements Cardiovasculaires Chez Les Personnes Vivant Avec Le Virus de L’Immuno-Deficience Humaine a L’Hopital Central de Yaounde - Liliane Mfeukeu, Cameroon

INTEREST 2024

Access to Innovative Biomedical Treatment and Prevention Tools in Low- and Middle-Income Countries - Tiwadayo Braimoh, MSc, MBA

INTEREST 2024

North and South Research Partnership - Glenda E. Gray, MBBCH, FCPaeds (SA), DSc

INTEREST 2024

ANRS MIE - Inmaculada Ortega Perez, PhD, MPH

INTEREST 2024

Plasma Viral Load of 200 Copies/ML Is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- And Middle- Income Countries: Evidence From a Facility-Based Study in Cameroon - Collinis Ambe Chenwi, Cameroon

INTEREST 2024

Effect of the COVID-19 Pandemic on Paediatric Antiretroviral Therapy Coverage in Sub–Saharan Africa: Findings From 43 Countries - Stella Atema, Nigeria

INTEREST 2024

Transitioning Children to Pediatric Dolutegravir (TORPEDO) Study: Endline Results in Benin, Nigeria, and Uganda - Dinesh Rathakrishnan, United States

INTEREST 2024

Profil de Mutation de Résistance Aux Inhibiteurs Nucléosidiques de la Transcriptase Inverse Chez Les Enfants ET Adultes en éChec Virologique en Côte D’Ivoire Dans Un Contexte de Basculement Systématique Sous (...)- Jean-Jacques Renaud Dechi, Côte d'Ivoire

INTEREST 2024

Augmentation du Taux de Rétention avec un Modèle de Prise en Charge Adaptée Combinant la Délégation des Tâches et le Suivi Différencié des PVVIH au Sénégal - Assane Diouf, Sénégal

INTEREST 2024

Beyond Surviving to Thriving for All Adolescents Living with HIV - Nicola Willis, BN (Hon), Mphil

INTEREST 2024

HIV & Cardiometabolic Disorders - Ntobeko Ntusi, BSc(Hons), MBChB, MD, DPhil

INTEREST 2024